Terug
Dagbereik
€ 10,88
€ 10,88
52-Weeksbereik
€ 3,28
€ 10,88
Volume
500
50D / 200D Gem.
€ 8,14
/
€ 4,95
Vorige Slotkoers
€ 10,88
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 361,3 | 0,3 |
| P/B | 7,9 | 2,9 |
| ROE % | 2,2 | 3,7 |
| Net Margin % | 2,3 | 3,8 |
| Rev Growth 5Y % | 205,9 | 10,0 |
| D/E | 0,9 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
-€ 0,34
-€ 0,52 – -€ 0,18
|
63 M | 1 |
| FY2028 |
€ 0,17
€ 0,09 – € 0,27
|
84 M | 1 |
| FY2027 |
€ 0,60
€ 0,33 – € 0,93
|
99 M | 1 |
Belangrijkste Punten
Revenue grew 205,92% annually over 5 years — strong growth
ROE of 2,20% is below average
Generating 14,22M in free cash flow
P/E of 361,25 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 71,36%
Cash machine — converts 943,66% of earnings into free cash flow
Groei
Revenue Growth (5Y)
205,92%
Revenue (1Y)134,56%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
2,20%
ROIC1,87%
Net Margin2,25%
Op. Margin4,90%
Veiligheid
Debt / Equity
0,90
Current Ratio1,23
Interest Coverage0,69
Waardering
P/E Ratio
361,25
P/B Ratio7,86
EV/EBITDA159,93
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 134,56% | Revenue Growth (3Y) | 82,15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 205,92% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 67,00M | Net Income (TTM) | 1,51M |
| ROE | 2,20% | ROA | 1,00% |
| Gross Margin | 99,55% | Operating Margin | 4,90% |
| Net Margin | 2,25% | Free Cash Flow (TTM) | 14,22M |
| ROIC | 1,87% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,90 | Current Ratio | 1,23 |
| Interest Coverage | 0,69 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 361,25 | P/B Ratio | 7,86 |
| P/S Ratio | 8,13 | PEG Ratio | -1,08 |
| EV/EBITDA | 159,93 | Dividend Yield | 0,00% |
| Market Cap | 544,40M | Enterprise Value | 524,75M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 67,00M | 28,57M | 20,20M | 80,07M | 765.000,0 |
| Net Income | 1,51M | -28,89M | -23,72M | 67,26M | -101,22M |
| EPS (Diluted) | 0,03 | -0,58 | -0,48 | 1,23 | -2,60 |
| Gross Profit | 66,70M | 28,22M | 19,95M | 79,91M | 563.000,0 |
| Operating Income | 3,28M | -26,58M | -27,29M | 31,82M | -82,90M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 151,42M | 173,87M | 215,54M | 281,72M | 198,61M |
| Total Liabilities | 82,20M | 105,92M | 121,01M | 162,62M | 214,78M |
| Shareholders' Equity | 69,22M | 67,95M | 94,53M | 119,10M | -16,16M |
| Total Debt | 62,13M | 70,18M | 75,28M | 74,24M | 185,69M |
| Cash & Equivalents | 81,79M | 77,79M | 136,00M | 258,76M | 171,03M |
| Current Assets | 92,77M | 113,12M | 158,46M | 268,10M | 184,72M |
| Current Liabilities | 75,16M | 38,48M | 39,37M | 62,84M | 31,07M |